Skip to main content

Table 1 Characteristics of and reported contraceptive use among HIV-positive respondents receiving antiretroviral therapy (ART) at 18 public sector clinics in Lusaka, Zambia (N = 7046)

From: Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional survey

  Women, N = 4872 Men, N = 2174
n (%) n (%)
Age 4405 1994
 Median (IQR) 34 (30–40) 40 (34–44)
 15–24 322 (8) 36 (2)
 25–34 1848 (42) 500 (25)
 35–49 2225 (51) 1244 (62)
  > 49 a 218 (11)
Client or partner currently pregnant 4686 1993
 Yes 313 (7) 150 (8)
 No, don’t know 4373 (93) 1843 (92)
Desire a child in the next year 4173 1839
 Yes 1023 (25) 492 (27)
 No, don’t know 3150 (75) 1347 (73)
HIV status disclosed to partner 4764 2129
 Yes 3706 (78) 1858 (87)
 No, don’t know 299 (6) 93 (4)
 No partner 759 (16) 178 (8)
Partner’s HIV status 4819 2147
 Negative 787 (16) 408 (19)
 Positive 2851 (59) 1455 (68)
 Unknown 346 (7) 92 (4)
 No partner 835 (17) 192 (9)
Sexually active in previous 6 months 4602 2028
 Yes 3526 (77) 1718 (85)
Using contraception 4542 2046
 Yes 3138 (69) 1608 (79)
 No 1404 (31) 438 (21)
Method of contraception used   
 Male condom 1867 (60) 1277 (79)
 Injectable contraception 484 (15) 124 (8)
 Oral contraceptive pill 342 (11) 96 (6)
 Sub-dermal implant 252 (8) 59 (4)
 Copper IUD 117 (4) 15 (1)
 Female condom 23 (1) 23 (1)
 Sterilization 11 (0.5) 1
 Other 8 7
Dual method use by those using contraception 797 (25) 217 (14)
Reasons for not using family planningb   
 No partner 639 (46) 134 (31)
 Desire pregnancy 250 (18) 71 (16)
 Partner opposed 115 (8) 33 (8)
 Fear of side effects 101 (7) 12 (3)
 Currently pregnant 112 (8) 50 (10)
 Other 336 (23) 126 (25)
Would obtain family planning in ART clinic 4140 1941
 Yes 3285 (79) 1637 (84)
 No, don’t know 855 (21) 304 (16)
  1. IQR interquartile range, IUD intrauterine device
  2. aWomen aged > 49 years were excluded
  3. bPercentages do not add to 100 as clients could select more than one reason